HNL Dimer in plasma is a unique and useful biomarker for the monitoring of antibiotic treatment in sepsis
Our data supports and confirms our earlier findings of HNL Dimer being a novel and potentially useful clinical tool in antibiotic stewardship in sepsis. HNL Total reflects epithelial cell activity in the body and is an interesting biomarker for the management of organ failure in such patients.
Authors
- Per Venge (ORCID: https://orcid.org/0000-0001-5863-790X)
- Jonas Tydén (ORCID: https://orcid.org/0000-0001-8598-9804)
- Joakim Johansson (ORCID: https://orcid.org/0000-0001-6866-0177)
- Christer Peterson
- Shengyuan Xu
- Anders Olof Larsson (ORCID: https://orcid.org/0000-0003-3161-0402)
Institutions
- Uppsala University (SE)
- Umeå University (SE)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1371/journal.pone.0310987
- Citations
- 1
- Primary Topic
- Sepsis Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.39